15 Recruiting Myelofibrosis Phase 1 Clinical Trials
Active phase 1 studies for myelofibrosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Myelofibrosis studiesPhase 1 Studies for Myelofibrosis
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
📍 University of Alabama At Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
📍 Local Institution - 0069 — Newport Beach, California
View Study & Checklist ➔A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
📍 City of Hope — Duarte, California
View Study & Checklist ➔Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)
📍 Thomas Jefferson University — Philadelphia, Pennsylvania
View Study & Checklist ➔Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Revumenib in Patients With Myelofibrosis
📍 Icahn School of Medicine at the Mount Sinai Hospital — New York, New York
View Study & Checklist ➔Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
📍 UC Davis Health — Sacramento, California
View Study & Checklist ➔AlloHCT With PegINFa for Myelofibrosis
📍 Huntsman Cancer Institute at the University of Utah — Salt Lake City, Utah
View Study & Checklist ➔Therapeutic RSK1 Targeting in Myelofibrosis
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
📍 Massachusetts General Hospital (Data Collection Only) — Boston, Massachusetts
View Study & Checklist ➔Momelotinib During and After HCT in Myelofibrosis
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
View Study & Checklist ➔Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔